Nishita Bakshi 

Marie Brown 

Anna Chau

Carrie Des Roches

Jennifer Fong

Caroline Toney-Noland

Sophia Wiggins 

(UCSF/UCSD): Rebecca Baer, MPH

Rebecca Baer serves as the Associate Director of Research for HOPE and as a Senior Epidemiologist. She is also a senior epidemiologist and analyst at UCSD and is a researcher with the UCSF California Preterm Birth Initiative.

UCSF: April Bell, PhD, MPH

April Bell is an Assistant Professor of Family Community Medicine in the UCSF School of Medicine and Co-Principal Investigator of our California population-based study of pregnancy and newborn outcomes. Dr. Bell's work focuses on decreasing reproductive health inequities among women and youth by addressing the impacts of societal and structural biases on adverse birth outcomes, sexually transmitted infections, HIV acquisition, abortion access, and unintended pregnancy.

UCSD: Tina Chambers, PhD, MPH

Dr. Chambers is a HOPE Consortium Co-Founder.She  is a Professor of Pediatrics at UCSD and is the Director of Clinical Research for the Department of Pediatrics at UCSD and at Rady Children's Hospital. She co-directs the Center for the Promotion of Maternal Health and Infant Development in the Department of Pediatrics at UCSD and is the President of MotherToBaby California. She is the Primary Investigator of the San Diego Study of Outcomes in Mother's and Infants (SOMI). 

NYU, UCSF: Laura Jelliffe-Pawlowski, PhD, MS

Laura Jelliffe-Pawlowski is the Primary Founder of the HOPE Consortium and serves as its lead. She is a Professor of Epidemiology and Precision Health in the Rory Meyers College of Nursing at New York University, an Emeritus Professor of Epidemiology & Biostatistics and of Global Health Sciences in the UCSF School of Medicine, and a senior faculty member with the UCSF California Preterm Birth Initiative. She is a Primary Investigator for the HOPE, CPPOP, and THRIVE studies and of the PROMPT study with Kelli Ryckman and Elizabeth Rogers.

Stanford University: Safyer McKenzie-Sampson, MSc

Safyer McKenzie-Sampson in an investigator with the HOPE Consortium and was previously a graduate student in the HOPE lab and with the California Preterm Birth Initiative. She is a postgraduate researcher at Stanford University. She is an expert in the role of structural racism on pregnancy outcomes and serves a key role in investigating these patterns across HOPE efforts.

UCSF: Scott Oltman, MS

Scott Oltman is a Senior Epidemiologist for Postnatal Investigations for the HOPE Consortium. He is a senior epidemiologist and analyst at UCSF in the Department of Biostatistics and Epidemiology and in Global Health Sciences and is a researcher with the UCSF California Preterm Birth Initiative.

UCSF: Larry Rand, MD

Larry Rand is a HOPE Consortium Co-Founder and serves as its Primary Lead of Maternal and Fetal Clinical Investigation. He is the Marc and Lynne Benioff Endowed Chair in Maternal Fetal Medicine in the Department of Obstetrics, Gynecology & Reproductive Sciences in the UCSF School of Medicine. He is the Primary Investigator of the UCSF California Preterm Birth Initiative. Dr. Rand also serves as Primary Lead of Maternal and Fetal Clinical Investigation for the HOPE COVID-19 study.

UCSF: Elizabeth Rogers, MD

Elizabeth Rogers is a HOPE Consortium Founder and serves as its Primary Lead of Newborn and Pediatric Clinical Investigation. She is a  Professor of Clinical Pediatrics in the School of Medicine in the Department of Pediatrics at UCSF, Associate Vice Chair for Faculty Development, and Director of the Intensive Care Nursery ROOTS Small Baby Program. Dr. Rogers also serves as Primary Lead of Newborn and Pediatric Investigation for the HOPE COVID-19 study and serves as a Principal Investigator on the PROMPT study with Laura Jelliffe-Pawlowski and Kelli Ryckman.

Indiana University: Kelli Ryckman, PhD, MS

Kelli Ryckman is a HOPE Consortium Co-Founder. Dr. Ryckman is a Professor of Epidemiology and Biostatistics and Associate Dean for Research in the Indiana University Bloomington School of Public Health. She is the Primary Investigator of the Cancer and Birth Outcomes study, a Primary Investigator on the PROMPT study (with  Laura Jelliffe-Pawlowski and Elizabeth Rogers).

UCSF: Martina Steurer, MD

Martina Steurer leads HOPE efforst focused on cardiac anomalies. She is a Professor in the Department of Pediatrics, Neonatology, Pediatric Critical Care and in the Department of Epidemiology and Biostatistics at UCSF. She is an expert in the care of infants and young children with preterm birth and with cardiac anomalies. She has led multiple studies focused on identifying risk and resiliency factors related to preterm birth, cardiac anomalies, and related outcomes.

UCSF: Louie Swander

Louie Swander has been a key member of the HOPE and PROMPT Study teams. Louie led UCSF coordination efforts focused on recruiting and following newborns born before 32 weeks at UCSF being followed as part of our multi-site NIH PROMPT study. 

University of Illinois Urbana-Champaign: Karen Tabb Dina, PhD, MSW

Karen Tabb Dina is HOPE investigator and co-lead of its perinatal mental health efforts. She a Professor in the School of Social Work and with the Beckman Institute at the University of Illinois at Urbana-Champaign. She is an expert in perinatal mental health and leads a number of efforts across the United States focused on increasing understanding of the links between mental health and pregnancy outcomes and on addressing and reducing the burden of mental health conditions during and after pregnancy -- particularly in minority populations.

UCSF: Deborah Adeyemi, MPH

Deborah Adeyemi is a Graduate Student Investigator with the HOPE Consortium and a PhD student in Epidemiology & Biostatistics at UCSF. Her research focuses on creating novel measures and models focused on hospital readmission and severe maternal morbidity - particularly in Black pregnant individuals.

UCSF Alumni Investigator: Ribka Amsalu Tessera, MD, MSc, MAS

Ribka Amsalu is an investigator with the HOPE Consortium. She is an alumni postdoctoral scholar with the UCSF California Preterm Birth Initiative whose research focuses on application of methods of epidemiology and clinical research to improve obstetric outcomes, and maternal and newborn health globally.

UCSF: Patience Afulani, PhD, MD, MPH

Patience Afulani is an investigator with the HOPE Consortium. She is an Associate Professor of Obstetrics, Gynecology, & Reproductive Sciences at UCSF whose research focuses on social and health systems factors that underlie inequities in reproductive, maternal, and neonatal health globally. 

UCSD: Gretchen Bandoli, PhD, MPH

Gretchen Bandoli is an investigator with the HOPE Consortium. She is an Associate Professor of Pediatrics, Family Medicine, and Public Health at UCSD whose research focuses on pregnancy and early childhood with a special focus on the impacts of complex exposures across gestation, including substances (alcohol, marijuana) and medications. She a Co-Primary Investigator of the San Diego Study of Outcomes in Mother's and Infants (SOMI). 

NYU: Mimi (Paulomi) Bhatt, PhD, MPH, CNM

Mimi Bhatt is an  investigator with the HOPE Consortium. She is an Assistant Professor at NYU Rory Meyers College of Nursing. She is a theorist, educator, researcher, and certified nurse-midwife. Her work explores the potential of integrated models of midwifery care in creating health equity in historically disenfranchised communities.

California State University, Northridge (CSUN): Kacie Blackman, PhD

Kacie Blackman is an investigator with the HOPE Consortium. She is an Associate Professor in the Health Equity and Research (HERE) Center and the Department of Health Sciences at California State University, Northridge whose research focuses on developing, implementing, evaluating, and disseminating culturally relevant sustainable research programs that promote health equity and health literacy.

Lundquist Institute, Harbor-UCLA: Bridgette Blebu, PhD, MPH

Bridget Blebu is an investigator with the HOPE Consortium. She is a Faculty Investigator at the Lundquist Institute at Hardbor-UCLA. Her research focuses on understanding drivers of preterm birth in black women with an emphasis on the role that enhanced prenatal care and psychosocial support during pregnancy has on pregnancy outcomes. 

NYU: Justin Brandt, MD

Justin Brandt is an investigator with the HOPE Consortium. He is Director of the Division of Maternal-Fetal Medicine and NYU Langone Hospital and an Associate Professor of Obstetrics and Gynecology at NYU Grossman School of Medicine who research focuses, in part, on bibliometrics (exploring how research findings are disseminated), chronic hypertension and stillbirth, and on births in people identifying as being transgender,

UCSF: Alexander Butwick, MBBS, MS

Alexander Butwick is an investigator with the HOPE Consortium. He is a Professor of Anesthesia at UCSF whose work and research focuses on the care and clinical experiences of pregnant people. His research has as a particular focus the study of postpartum hemorrhage and other conditions like postpatum anemia. He has also done extensive work with respect to the use of epidural labor analgesia.

UCSF: Kimberly Coleman-Phox, MPH

Kimberly Coleman-Phox is an investigator with the HOPE Consortium. She is Associate Director of Healthcare Interventions with the UCSF California Preterm Birth Initiative and is a portfolio manager with the California Collaborative for Public Health Research (CPR3). She is an expert in faciitating and supporting community-engaged research - particularly with respect to investigations with pregnant and postpartum people.

University of Iowa: John Dagle, MD, PhD

John Dagle is an investigator with the HOPE Consortium. He is an expert in the study of  in the optimization of nutrition in infants born preterm and in understanding the role of feeding in newborn development and health. He works closely with HOPE collaborators on the PROMPT study and related efforts efforts focused on better understanding the role of newborn metabolism in outcomes amoung babies with preterm birth. 

Providence St Joseph Health: Alexa Dowdell, MS

Alexa Dowdell is an investigator with the HOPE Consortium. She is a is Senior Bioinformatics Scientist in the Earle A. Chiles Research Institute at Providence St. Joseph Health. Her work focuses on investigating multi-omic drivers of disease.

UCSF: Jennifer Felder, PhD

Jennifer Felder is an investigator with the HOPE Consortium. She is an Associate Professor of Psychiatry in the UCSF Weill Institute for Neurosciences within the UCSF School of Medicine whose work focuses on promoting mental health during and after pregnancy. She is an expert in evaluating treatments to promote sleep and prevent depression during pregnancy which aligns closely with the work she does with the HOPE Consortium.

UCSF: Elena Flowers, PhD, RN

Elena Flowers is an investigator with the HOPE Consortium.. She is a Professor of Physiologic Nursing at UCSF whose research program focuses on precision medicine and type 2 diabetes in high risk racial groups. Dr. Flowers contributes this expertise to the collaborative specifically as it relates to how biomarkers are associated with type 2 diabetes and related conditions during pregnancy.

San Francisco Department of Public Health: Jonathan Fuchs, MD, MPH

Jonathan Fuchs is an investigator with the HOPE Consortium. He is a Clinical Professor of Medicine at UCSF and is also the Director of the Center for Learning and Innovation at the San Francisco Department of Public Health. He also serves as a director with the UCSF California Preterm Birth Initiative. Dr. Fuchs contributes his extensive experience in clinical medicine with the collaborative as well as his expertise in collective impact and community engagement.

UCSF: Dawn Gano, MD, MAS

Dawn Ganois an investigator with the HOPE Consortium. She is an Associate Professor of Neurology at UCSF and serves as the Clinical Director of the Fetal Neurology Center of Excellence and Associate Director of Neonatal Neurocritical Care Services. Her research focuses on improving understanding of the causes and consequences of injury to the developing brain in utero. Dr. Gano contributes this expertise to the collaborative where she is a partner on multiple studies.

NYU: Dana Gossett, MD

Dana Gossett is an investigator with the HOPE Consortium. She is Chair of the Department of Obstetrics and Gynecology at NYU Langone Health and in the NYU Grossman School of Medicine. She brings extensive research experience in mental health and pregnancy, sexual function and obstetric trauma, and health policy and systems research to HOPE.

NYU: Sasha Hernendez, MD

Sasha Hernandez is an investigator with the HOPE Consortium. She is an Assistant Professor of Obstetrics and Gynecology and of Population Health in the NYU Grossman School of Medicine and is an Obstetrician and Gynecologist at NYU Langone Health. She is an expert in conducting community-engaged reserach in the U.S. and globally with a focus on improving equitable access to care.

Infectious Disease Research Collaboration (IDRC)/ Makereree University, Uganda: Moses Kamya, MBChB, MMed, MPH, PhD

Moses Kamya is an investigator with the HOPE Consortium. He is Professor and Chair of the Department of Medicine at Makerere University in Uganda and is the Executive Director of the Infectious Disease Research Collaborative (IDRC) in Uganda. He is a global leader in the study of malaria and works extensively with investigators throughout the world to better understand drivers of malaria and related illnesses. Dr. Kamya works with HOPE collaborators on investigations in Uganda focused on assessing whether metabolic models that predict maturity, morbidity, and mortality among newborns in the US translate into developing settings.

NYU: Shuyuan Huang, MPH, PhD, RN

Shuyuan Huang is a post-doctoral investigator with the HOPE Consortium and a Postdoctoral Fellow in the NYU Rory Meyers College of Nursing. Her  research focuses on the intersection of chronic disease prevention and minority and immigrant health. She contributes this expertise to the HOPE Consortium where she partners on efforts aimed at better understanding links between chronic disease and pregnancy outcomes.

UCSF: Kayla Karvonen, MD

Kayla Karvonen is an investigator with the HOPE Consortium. She is an Assistant Professor of Pediatrics at UCSF whose research focuses on investigating and addressing racial and ethnic inequities in the delivery of neonatal care and neonatal outcomes. Dr. Karvonen contributes this expertise to the HOPE Consortium where she leads and partners on studies leveraging hospital- and population-based data to better understand neonatal outcomes and care - especially in minority populations.

UCSF: Miriam Kuppermann, PhD, MPH

Miriam Kuppermann is an investigator with the HOPE Consortium. She is a professor at UCSF in the Departments of Obstetrics, Gynecology & Reproductive Sciences at UCSF. She is also the Director of the Preconception and Prenatal Interventions and the Postdoctoral Fellowship Program for the UCSF California Preterm Birth Initiative. She is an expert in comparative effectiveness research and in studies focused on patient-centered outcomes - particularly as they relate to pregnancy and pregnancy outcomes.

UCSF: Kayla Longoria, PhD, MA, RN

Kayla Longoria is a Postdoctoral Investigator with the HOPE Consortium and a Postdoctoral Scholar in the UCSF School of Nursing. Her research focuses on perinatal mental health and precision health methodologies that includes multi-omic phenotyping and risk detection. 

Medical College of Wisconsin: Liang Liang, PhD

Liang Liang is an investigator with the HOPE Consortium. Her work focuses on the biological processes involved in maternal-infant health, with particular emphasis on preterm birth and its connection to metabolic dysregulation. By employing metabolomics and other cutting-edge technologies, her work aims to identify biomarkers that could lead to improved prediction and prevention strategies for pregnancy complications.  

NYU: Audrey Lyndon, FAAN, PhD, RNC

Audrey Lyndon is an investigator with the HOPE Consortium. She is an Executive Vice Dean and the Vernice D. Ferguson Professor in Health Equity in the NYU Rory Meyers School of Nursing. She has deep expertise in research focused on severe maternal morbidity and mortality, including with respect to understanding patterns and related inequities and overlaps with outcomes like preterm birth.. 

UCSF: Charles McCulloch, PhD

Charles McCullochis an investigator with the HOPE Consortium. He is an Emeritus Professor of Biostatistics in the Department of Epidemioloy & Biostatistics at UCSF whose work spans a myriad of health outcomes where he contributes key biostatistical expertise.

NYU: Monica McLemore, FADLN, MPH, PhD, RN

Monica Mclemore is an investigator with the HOPE Consortium. She is a Visiting Professor at NYU Rory Meyers College of Nursing and is leading scholar in antiracist birth equity research and a national expert on reproductive health, rights, and justice. She is Editor-in-Chief of the journal "Health Equity".. 

University of Iowa: Allison Momany, PhD

Alison Momany is an investigator with the HOPE Consortium. She is an Assistant Professor of Psychiatry  whose work focuses on better understanding the impacts of advserse pregnancy outcomes, like preterem birth, on neurodevelopmental outcomes in infancy and early childhood.

UCSF: Matt Pantell, MD, MS

Matt Pantell is an investigator with the HOPE Consortium. He is an Associate Professor in the Department of Pediatrics in the School of Medicine at UCSF. His research focuses on implementing social needs screening in clinical settings, the utility of incorporating social information into clinical decision making, addressing social needs in clinical settings, data mining and the analysis of large datasets, and biological manifestations of the social determinants of health.

UCSF: Mark Petersen, MD

Mark Petersen is an investigator with the HOPE Consortium. He is an Associate Professor of Pediatrics in the UCSF School of Medicine whose research centers on investigation of vascular mechanisms of neurological disease and injury in newborns. His work focuses specifically on identifying therapies that can can help buffer against or treat injury.

Providence St Joseph Health: Brian Piening, PhD

Brian Piening is an investigator with the HOPE Consortium. He is the Director of Providence Genomics whose work focuses on precision and personalized medicine as informed my multi-omic patterns and signaling. He and his team have created ground-breaking AI tools focused on early tumor discovery and cancer diagnosis. He brigs this expertise to HOPE.

UCSF: Carolyn Ponting, PhD

Carolyn Ponting is a Postdoctoral Investigator with the HOPE Consortium and a Postdoctoral Research Fellow in the Osher Center for Integrative Health at UCSF. She is a clinical psychologist whose work focuses on prenatal anxiety, depression, and traumatic stress which she brings to her work with the HOPE Consortium.

University of Alabama Birmingham: Akila Subramanium, MD, MPH

Akila Subramaniam is an investigator with the HOPE Consortium. She is an Associate Professor in the Division of Maternal-Fetal Medicine at the University of Alabama Birmingham. Her research focuses on using novel metagenomic and molecular sequencing methods to study interactions between the microbiome, perinatal infections and preterm birth.

UCSF: Alexandra Sullivan, PhD

Alexandra Sullivan is a Postdoctoral Investigator with the HOPE Consortium and a Postdoctoral Scholar in Psychiatry in the UCSF School of Medicine whose work focuses on understanding how interventions related to anxiety and oher conditions affect biomarker signaling. 

UCSF: Kelli Taylor, PhD, MS, MPH

Kelli Taylor is an investigator with the HOPE Consortium. She is an Assistant Professor of Medicine. She is a behavioral scientist with a background in community psychology, epidemiology, and evaluation methodology. She is an expert in bio-behavioral research with groundbreaking studies in the United States and Africa.